In another work, patients with rheumatoid arthritis also manifested lower plasma concentrations of 4-β-hydroxycholesterol (an endogenous metabolite of CYP3A4) than did healthy controls [414]. Here, CYP3A4 is linked to rheumatoid arthritis.